ZuriMED receives support from Innosuisse with a grant of CHF 2.4 million to expedite product development and regulatory registration of a second Surgical-Fiberlock™ device
Menu

28.04.2023

ZuriMED Technologies AG

ZuriMED receives support from Innosuisse with a grant of CHF 2.4 million to expedite product development and regulatory registration of a second Surgical-Fiberlock™ device

Innosuisse launched a call for projects for the Swiss Accelerator in 2022 as a transitional measure for Horizon Europe. Following a three-stage assessment process, Innosuisse has now approved 53 innovation projects by SMEs and start-ups with significant innovation potential. ZuriMED Technologies AG is one of the fifty three supported projects. 

Exhibitor Data Sheet